Compare OMH & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMH | VNRX |
|---|---|---|
| Founded | 2015 | N/A |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7M | 31.9M |
| IPO Year | 2022 | 2012 |
| Metric | OMH | VNRX |
|---|---|---|
| Price | $1.25 | $0.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 23.9K | ★ 14.4M |
| Earning Date | 11-28-2025 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,233,511.00 |
| Revenue This Year | $28.40 | $68.22 |
| Revenue Next Year | $23.07 | $382.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 59.10 |
| 52 Week Low | $0.59 | $0.17 |
| 52 Week High | $4.33 | $0.94 |
| Indicator | OMH | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.78 | 45.39 |
| Support Level | $1.03 | $0.17 |
| Resistance Level | $1.37 | $0.27 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 60.98 | 18.73 |
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.